In vitro and in vivo evidence of the importance of organic anion transporters (OATs) in drug therapy

Handbook of Experimental Pharmacology

Volumn 201, Issue , 2011, Pages 29-104

  Burckhardt, Gerhard ^a   Burckhardt, Birgitta Christina ^a  

^a Zentrum Physiol/Pathophysiologie   (Germany)

Author keywords

ACE inhibitors; Antibiotics; Antidiabetics; Antineoplastics; Antivirals; AT1 receptor blockers; Diuretics; Drug drug interaction; Gender differences; Histamine receptor antagonists; Kidney; NSAIDs; Organic anion transporter; Proximal tubule; Single nucleotide polymorphisms; Species differences; Statins; Tissue localization

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTACID AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; ANTIHISTAMINIC AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; CARRIER PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; ORGANIC ANION TRANSPORTER; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 10; ORGANIC ANION TRANSPORTER 2; ORGANIC ANION TRANSPORTER 3; ORGANIC ANION TRANSPORTER 4; ORGANIC ANION TRANSPORTER 5; ORGANIC ANION TRANSPORTER 6; ORGANIC ANION TRANSPORTER 7; ORGANIC ANION TRANSPORTER 8; PENICILLIN G; PROBENECID; UNCLASSIFIED DRUG; UNINDEXED DRUG; URATE TRANSPORTER 1; URICOSURIC AGENT;

AGE DISTRIBUTION; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG PROTEIN BINDING; DRUG TRANSPORT; ENZYME SUBSTRATE; GENE LOCATION; HUMAN; IMMUNOLOCALIZATION; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR CLONING; NONHUMAN; PHARMACOGENOMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; SEX DIFFERENCE; SPECIES DIFFERENCE; TISSUE DISTRIBUTION;

AGE FACTORS; ANIMALS; BIOLOGICAL TRANSPORT; DRUG INTERACTIONS; EVIDENCE-BASED MEDICINE; GENOTYPE; HUMANS; KIDNEY; ORGANIC ANION TRANSPORTERS; PHARMACEUTICAL PREPARATIONS; PHARMACOGENETICS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX FACTORS; SPECIES SPECIFICITY;

EID: 78649665012     PISSN: 01712004     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-14541-4_2     Document Type: Review

References (309)

1. Aherne GW, Marks V, Mould GP et al (1978) The interaction between methotrexate and probenecid in man. Br J Pharmacol 63:369P
2. Ahn S-Y, Eraly SA, Tsigelny I, Nigam SK (2009) Interaction of organic cations with organic anion transporters. J Biol Chem 284:31422-31430
3. Alebouyeh M, Takeda M, Onozato ML et al (2003) Expression of human organic anion transporters in the choroid plexus and their interactions with neurotransmitter metabolites. J Pharmacol Sci 93:430-436
4. Aleksunes LM, Augustine LM, Scheffer GL et al (2008) Renal xenobiotic transporters are differentially expressed in mice following cisplatin treatment. Toxicology 250:82-88
5. Anzai N, Miyazaki H, Noshiro R et al (2004) The multivalent PDZ domain-containing protein PDZK1 regulates transport activity of renal urate-anion exchanger URAT1 via its C terminus. J Biol Chem 279:45942-45950
6. Anzai N, Jutabha P, Enomoto A et al (2005) Functional characterization of rat organic anion transporter 5 (Slc22a19) at the apical membrane of renal proximal tubules. J Pharmacol Exp Ther 315:534-544
7. Anzai N, Kanai Y, Endou H (2006) Organic anion transporter family: current knowledge. J Pharm Sci 100:411-426
8. Aoki J, Saso N, Kato S et al (2008) Nitric oxide and peroxinitrite regulate transporter transcription in rat liver slices. Biol Pharm Bull 31:1882-1887
9. Apiwattanakul N, Sekine T, Chairoungdua A et al (1999) Transport properties of nonsteroidal antiinflammatory drugs by organic anion transporter 1 expressed in Xenopus laevis oocytes. Mol Pharmacol 55:847-854
10. Asif AR, Steffgen J, Metten M et al (2005) Presence of organic anion transporters 3 (OAT3) and 4 (OAT4) in human adrenocortical cells. Pflügers Arch Eur J Physiol 450:88-95
11. Aslamkhan AS, Han Y-H, Yang X-P et al (2003) Human renal organic anion transporter 1-dependent uptake and toxicity of mercuric-thiol conjugates in Madin-Darby canine kidney cells. Mol Pharm 63:590-596
12. Aslamkhan AG, Thompson DM, Perry JL et al (2006) The flounder organic anion transporter (fOAT) has sequence, function and substrate specificity similar to both mammalian Oats 1 and 3. Am J Physiol Regul Integr Comp Physiol 291: R1773-R1780
13. Augustine LM, Markelewicz RJ, Boekelheide K, Cherrington NJ (2005) Xenobiotic and endobiotic transporter mRNA expression in the blood testis barrier. Drug Metab Dispos 33:182-189
14. Babu E, Takeda M, Narikawa S et al (2002) Human organic anion transporters mediate the transport of tetracycline. Jpn J Pharmacol 88:69-76 (Pubitemid 34139841)
15. Babu E, Takeda M, Narikawa S et al (2002) Role of human organic anion transporter 4 in the transport of ochratoxin A. Biochim Biophys Acta 1590:64-75 (Pubitemid 34626769)
16. Bahn A, Prawitt D, Butler G et al (2000) Genomic structure and in vivo expression of the human organic anion transporter 1 (hOAT1) gene. Biochem Biophys Res Commun 275:623-630
17. Bahn A, Knabe M, Hagos Y et al (2002) Interaction of the metal chelator 2, 3-dimercapto-1-propane sulfonate with the rabbit multispecific organic anion transporter 1 (rbOAT1). Mol Pharmacol 62:1128-1136
18. Bahn A, Ebbinghaus D, Ebbinghaus EG et al (2004) Expression studies and functional characterization of human organic anion transporter 1 isoforms. Drug Metab Dispos 32:424-430
19. Bahn A, Ljubojevic M, Lorenz H et al (2005) Murine renal organic anion transporters mOAT1 and mOAT3 facilitate the transport of neuroactive tryptophan metabolites. Am J Physiol Cell Physiol 289: C1075-C1084
20. Bahn A, Hagos Y, Reuter S et al (2008) Identification of a new urate and high affinity nicotinate transporter, hOAT10 (SLC22A13). J Biol Chem 283:16332-16341
21. Bakhiya N, Bahn A, Burckhardt G, Wolff NA (2003) Human organic anion transporter 3 (hOAT3) can operate as an exchanger accepting urate as a substrate. Cell Physiol Biochem 13:249-256
22. Bakhiya N, Batke M, Laake J et al (2007) Directing role of organic anion transporters in the excretion of mercapturic acids of alkylated polycyclic hydrocarbons. Drug Metab Dispos 35:1824-1831
23. Bakhiya N, Arlt VM, Bahn A et al (2009) Molecular evidence for an involvement of organic anion transporters (OATs) in aristolochic acid nephropathy. Toxicology 264:74-79
24. Barros SA, Srimaroeng C, Perry JL et al (2009) Activation of protein kinase Cz increases OAT1 (SLC22A6) - and OAT3 (SLC22A8)-mediated transport. J Biol Chem 284:2672-2679
25. Beéry E, Middel P, Bahn A et al (2003) Molecular evidence of organic ion transporters in the rat adrenal cortex with adrenocorticotropin- regulated zonal expression. Endocrinology 144:4519-4526
26. Beyer KH, Russo HF, Tillson EK et al (1951) 'Benemid', p-(di-n-propylsulfamyl)-benzoic acid: its renal affinity and its elimination. Am J Physiol 166:625-649
27. Bhatnagar V, Xu G, Hamilton BA et al (2006) Analyses of 50 regulatory region polymorphisms in human SLC22A6 (OAT1) and SLC22A8 (OAT3). J Hum Genet 51:575-580
28. Bleasby K, Hall LA, Perry JL et al (2005) Functional consequences of single nucleotide polymorphisms in the human organic anion transporter hOAT1 (SLC22A6). J Pharmacol Exp Ther 314:923-931
29. Bleasby K, Castle JC, Robert CJ et al (2006) Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: a resource for investigations into drug disposition. Xenobiotica 36:963-988
30. Brady KP, Dushkin H, Förnzler D et al (1999) A novel putative transporter maps to the osteosclerosis (oc) mutation and is not expressed in the oc mutant mouse. Genomics 56:254-261
31. Brandoni A, Quaglia NB, Torres AM (2003) Compensation increase in organic anion secretion in rats with acute biliary obstruction: role of the renal organic anion transporter 1. Pharmacology 68:57-63
32. Brandoni A, Anzai N, Kanai Y et al (2006) Renal elimination of p-aminohippurate (PAH) in response to three days of biliary obstruction in the rat. The role of OAT1 and OAT3. Biochim Biophys Acta 1762:673-681
33. Brandoni A, Villar SR, Picena JC et al (2006) Expression of rat renal cortical OAT1 and OAT3 in response to acute biliary obstruction. Hepatology 43:1092-1110
34. Brown GR (1993) Cephalosporin-probenecid drug interactions. Clin Pharmacokinet 24:289-300
35. Buist S C N, Klaassen CD (2004) Rat and mouse differences in gender-predominant expression of organic anion transporter (Oat1-3, Slc22a6-8) mRNA levels. Drug Metab Dispos 32:620-625
36. Buist S C N, Cherrington NJ, Choudhuri S et al (2002) Gender-specific and developmental influences on the expression of rat organic anion transporters. J Pharmacol Exp Ther 301:145-151
37. Buist S C N, Cherrington NJ, Klaassen CD (2003) Endocrine regulation of renal organic anion transporters. Drug Metab Dispos 31:559-564
38. Burckhardt BC, Burckhardt G (2003) Transport of organic anions across the basolateral membrane of proximal tubule cells. Rev Physiol Biochem Pharmacol 146:95-158
39. Burckhardt G, Wolff NA (2000) Structure of renal organic anion and cation transporters. Am J Physiol Renal Physiol 278: F853-F866
40. Burckhardt BC, Brai S, Wallis S et al (2003) Transport of cimetidine by flounder and human renal organic anion transporter 1. Am J Physiol Renal Physiol 284: F503-F509
41. Cha SH, Sekine T, Kusuhara H et al (2000) Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta. J Biol Chem 275:4507-4512
42. Cha SH, Sekine T, Fukushima J-I et al (2001) Identification and characterization of human organic anion transporter 3 expressing predominantely in the kidney. Mol Pharm 59:1277-1286 (Pubitemid 32385197)
43. Cha SH, Kim HP, Jung N-H et al (2002) Down-regulation of organic anion transporter 2 mRNA expression by nitric oxide in primary cultured rat hepatocytes. IUBMB Life 54:129-135
44. Chen J, Terada T, Ogasawara K et al (2008) Adaptive responses of renal organic anion transporter 3 (OAT3). Am J Physiol Renal Physiol 295: F247-F252
45. Cheng Q, Aleksunes LM, Manautou JE et al (2008) Drug-metabolizing enzyme and transporter expression in a mouse model of diabetes and obesity. Mol Pharm 5:77-91
46. Cheong HI, Kang JH, Lee JH et al (2005) Mutational analysis of idiopathic renal hypouricemia. Pediatr Nephrol 20:886-890
47. Cherrington NJ, Slitt AL, Li N, Klaassen CD (2004) Lipopolysaccharide- mediated regulation of hepatic transporter mRNA levels in rats. Drug Metab Dispos 32:734-741
48. Choudhuri S, Cherrington NJ, Li N, Klaassen CD (2003) Constitutive expression of various xenobiotic and endobiotic transporter mRNAs in the choroid plexus. Drug Metab Dispos 31:1337-1345
49. Chu X-Y, Bleasby K, Yabut J et al (2007) Transport of the dipeptidyl peptidase-4 inhibitor sitagliptin by human organic anion transporter 3, organic anion transporting polypeptide 4C1, and multidrug resistance P-glycoprotein. J Pharmacol Exp Ther 321:673-683
50. Cihlar T, Ho ES (2000) Fluorescence-based assay for the interaction of small molecules with the human renal organic anion transporter 1. Anal Biochem 283:49-55
51. Cihlar T, Lin DC, Pritchard JB et al (1999) The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1. Mol Pharm 56:570-580
52. Cropp CD, Komori T, Shima JE et al (2008) Organic anion transporter 2 (SLC22A7) is a facilitative transporter of cGMP. Mol Pharmacol 73:1151-1158
53. Cundy KC, Petty BC, Flaherty J et al (1995) Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 39:1247-1251
54. Cundy KC, Li Z-H, Lee WA (1996) Effect of probenecid on the distribution, metabolism, and excretion of cidofovir in rabbits. Drug Metab Dispos 24:315-321
55. Cunningham RF, Israeli ZH, Dayton PG (1981) Clinical pharmacokinetics of probenecid. Clin Pharmacokinet 6:135-151
56. Cunningham R, Brazie M, Kanumuru S et al (2007) Sodium-hydrogen exchanger regulatory factor-1 interacts with mouse urate transporter 1 to regulate renal proximal tubule uric acid transport. J Am Soc Nephrol 18:1419-1425
57. Dan H, Peng R-X, Ao Y, Liu Y-H (2008) Segment-specific proximal tubule injury in tripterygium glycosides intoxicated rats. J Biochem Mol Toxicol 22:422-428
58. Debelle FD, Vanherweghem J-L, Nortier JL (2008) Aristolochic acid nephropathy: a worldwide problem. Kidney Int 74:158-169
59. Deguchi T, Kusuhara H, Takadate A et al (2004) Characterization of uremic toxin transport by organic anion transporters in the kidney. Kidney Int 65:162-174
60. Di Giusto G, Anzai N, Endou H, Torres AM (2008) Elimination of organic anions in response to an early stage of renal ischemia-reperfusion in the rat: role of basolateral plasma transporters and cortical renal blood flow. Pharmacology 81:127-136
61. Di Giusto G, Anzai N, Ruiz ML et al (2009) Expression and function of Oat1 and Oat3 in rat kidney exposed to mercuric chloride. Arch Toxicol 83:889-897
62. Dreisbach AW (2009) The influence of chronic renal failure on drug metabolism and transport. Clin Pharmacol Ther 86:553-556
63. Dreisbach AW, Lertora J J L (2008) The effect of chronic renal failure on drug metabolism and transport. Expert Opin Drug Metab Toxicol 4:1065-1074
64. Dresser MJ, Leabman MK, Giacomini KM (2001) Transporters involved in the elimination of drugs in the kidney: organic anion transporters and organic cation transporters. J Pharm Sci 90:397-421
65. Ekaratanawong S, Anzai N, Jutabha P et al (2004) Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules. J Pharm Sci 94:297-304
66. Enomoto A, Endou H (2005) Roles of organic anion transporters (OATs) and urate transporter (URAT1) in the pathophysiology of human disease. Clin Exp Nephrol 9:195-205
67. Enomoto A, Niwa T (2007) Roles of organic anion transporters in the progression of chronic renal failure. Ther Apher Dial 11:327-331
68. Enomoto A, Kimura H, Chairoungdua A et al (2002) Molecular identification of a renal urateanion exchanger that regulates blood urate levels. Nature 417:447-452
69. Enomoto A, Takeda M, Shimoda S et al (2002) Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors. J Pharmacol Exp Ther 301:797-802 (Pubitemid 34595067)
70. Enomoto A, Takeda M, Tojo A et al (2002) Role of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity. J Am Soc Nephrol 13:1711-1720
71. Enomoto A, Takeda M, Taki K et al (2003) Interactions of human organic anion as well as cation transporters with indoxyl sulfate. Eur J Pharmacol 466:13-20
72. Eraly SA, Blantz RC, Bhatnagar V, Nigam SK (2003) Novel aspects of renal organic anion transporters. Curr Opin Nephrol Hypertens 12:551-558
73. Eraly SA, Hamilton BA, Nigam SK (2003) Organic anion and cation transporters occur in pairs of similar and similarly expressed genes. Biochem Biophys Res Commun 300:333-342
74. Eraly SA, Vallon V, Vaughn DA et al (2006) Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knock-out mice. J Biol Chem 281:5072-5083
75. Erdman AR, Mangravite LM, Urban TJ et al (2005) The human organic anion transporter 3 (OAT3; SLC22A8): genetic variation and functional genomics. Am J Physiol Renal Physiol 290:905-912
76. Feng B, Dresser MJ, Shu Y et al (2001) Arginine 454 and lysine 370 are essential for the anion specificity of the organic anion transporter, rOAT3. Biochemistry 40:5511-5520
77. Feng B, Shu Y, Giacomini KM (2002) Role of aromatic transmembrane residues of the organic anion transporter, rOAT3, in substrate recognition. Biochemistry 41:8941-8947
78. Frenia ML, Long KS (1992) Methotrexate and nonsteroidal anti-inflammatory drug interactions. Ann Pharmacother 26:342-343
79. Fujita T, Brown C, Carlson EJ et al (2005) Functional analysis of polymorphisms in the organic anion transporter, SLC22A6 (OAT1). Pharmacogenet Genomics 15:201-209
80. George RL, Wu X, Fei FH et al (1999) Molecular cloning and characterization of a polyspecific organic anion transporter from Caenorhabditis elegans. J Pharmacol Exp Ther 291:596-603
81. Gopal E, Fei Y-J, Sugawara M et al (2004) Expression of slc5a8 in kidney and its role in Na+-coupled transport of lactate. J Biol Chem 279:44533-44532
82. Groves CE, Suhre WB, Cherrington NJ, Wright SH (2006) Sex differences in the mRNA, protein, and functional expression of organic anion transporter (Oat) 1, Oat3, and organic cation transporter (Oct) 2 in rabbit renal proximal tubules. J Pharmacol Exp Ther 316:743-752
83. Habu Y, Yano I, Okuda M et al (2005) Restored expression and activity of organic ion transporters rOAT1, rOAT3 and rOCT2 after hyperuricemia in the rat kidney. Biochem Pharmacol 69:993-999
84. Hagos Y, Bahn A, Asif AR et al (2002) Cloning of the pig renal organic anion transporter 1 (pOAT1). Biochimie 84:1221-1224 (Pubitemid 36372170)
85. Hagos Y, Braun IM, Krick W et al (2005) Functional expression of pig renal organic anion transporter 3 (pOAT3). Biochimie 87:421-424
86. Hagos Y, Bahn A, Vormfelde SV et al (2007) Torasemide transport by organic anion transporters contributes to hyperuricemia. J Am Soc Nephrol 18:3101-3109
87. Hagos Y, Stein D, Ugele B et al (2007) Human renal organic anion transporter 4 operates as an asymmetric urate transporter. J Am Soc Nephrol 18:430-439 (Pubitemid 46193309)
88. Hagos Y, Krick W, Braulke T et al (2008) Organic anion transporters OAT1 and OAT4 mediate the high affinity transport of glutarate derivatives accumulating in patients with glutaric acidurias. Pflügers Arch Eur J Physiol 457:223-231
89. Hasannejad H, Takeda M, Taki K et al (2003) Interactions of human organic anion transporters with diuretics. J Pharmacol Exp Ther 308:1021-1029
90. Hasegawa M, Kusuhara H, Sugiyama D et al (2002) Functional involvement of rat organic anion transporter 3 (rOAT3; Slc22a8) in the uptake of organic anions. J Pharmacol Exp Ther 300:746-753
91. Hasegawa M, Kusuhara H, Endou H, Sugiyama Y (2003) Contribution of organic anion transporters to the renal uptake of anionic compounds and nucleoside derivatives in rat. J Pharmacol Exp Ther 305:1087-1097
92. Hashimoto T, Narikawa S, Huang X-L et al (2004) Characterization of the renal tubular transport of zonampanel, a novel alpha-amino-3-hydroxy-5- methylisoxazole-4-propionic acid receptor antagonist, by human organic anion transporters. Drug Metab Dispos 32:1096-1102
93. Hediger MA, Johnson RJ, Miyazaki H, Endou H (2005) Molecular physiology of urate transport. Physiology 20:125-133
94. Hilgendorf C, Ahlin G, Seithel A et al (2007) Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines. Drug Metab Dispos 35:1333-1340
95. Ho RH, Kim RB (2005) Transporters and drug therapy: implications for drug disposition and disease. Clin Pharmacol Ther 78:260-277
96. Ho ES, Lin DC, Mendel DB, Cihlar T (2000) Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. J Am Soc Nephrol 11:383-393
97. Höcherl K, Schmidt C, Bucher M (2009) COX-2 inhibition attenuates endotoxin-induced downregulation of organic anion transporters in the rat renal cortex. Kidney Int 75:373-380
98. Homeida M, Roberts C, Branch RA (1977) Influence of probenecid and spironolacton on furosemide kinetics and dynamics in man. Clin Pharmacol Ther 22:402-409
99. Honari J, Blair AD, Cutler RE (1977) Effects of probenecid on furosemide kinetics and natriuresis in man. Clin Pharmacol Ther 22:395-401
100. Hong M, Zhou F, You G (2004) Critical amino acid residues in transmembrane domain 1 of human organic anion transporter 1 OAT1. J Biol Chem 279:31478-31482
101. Hong M, Tanaka K, Pan Z et al (2007) Determination of the external loops and the cellular orientation of the N-and the C-termini of the human organic anion transporter hOAT1. Biochem J 401:515-520
102. Hosoyamada M, Sekine T, Kanai Y, Endou H (1999) Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. Am J Physiol Renal Physiol 276: F122-F128 (Pubitemid 29061732)
103. Hosoyamada M, Ichida K, Enomoto A et al (2004) Function and localization of urate transporter 1 in mouse kidney. J Am Soc Nephrol 15:261-268
104. Hu S, Franke RM, Filipski KK et al (2008) Interaction of imatinib with human organic ion carriers. Clin Cancer Res 14:3141-3148
105. Huang Q, Dunn RT, Jayadev S et al (2001) Assessmant of cisplatin-induced nephrotoxicity by microarray technology. Toxicol Sci 63:196-207
106. Ichida K, Hosoyamada M, Kimura H et al (2003) Urate transport via human PAH transporter hOAT1 and its gene structure. Kidney Int 63:143-155
107. Ichida K, Hosoyamada M, Hisatome I et al (2004) Clinical and molecular analysis of patients with renal hypouricemia in Japan - influence of URAT1 gene on urinary urate excretion. J Am Soc Nephrol 15:164-173
108. Imaoka T, Kusuhara H, Adachi-Akahane S et al (2004) The renal-specific transporter mediates facilitative transport of organic anions at the brush border membrane of mouse renal tubules. J Am Soc Nephrol 15:2012-2022
109. Islinger F, Gekle M, Wright SH (2001) Interaction of 2, 3-dimercapto-1-propane sulfonate with the human organic anion transporter hOAT1. J Pharmacol Exp Ther 299:741-747
110. Iwanaga T, Kobayashi D, Hirayama M et al (2005) Involvement of uric acid transporter in increased clearance of the xanthine oxidase inhibitor oxypurinol induced by a uricosuric agent, benzbromarone. Drug Metab Dispos 33:1791-1795
111. Iwanaga T, Sato M, Maeda T et al (2007) Concentration-dependent mode of interaction of angiotensin II receptor blockers with uric acid transporter. J Pharmacol Exp Ther 320:211-217
112. Jacobsson JA, Haitina T, Lindblom J, Fredriksson R (2007) Identification of six putative human transporters with structural similarity to the drug transporter SLC22 family. Genomics 90:595-609
113. Jariyawat S, Sekine T, Takeda M et al (1999) The interaction and transport of ß-lactam antibiotics with the cloned rat renal organic anion transporter 1. J Pharmacol Exp Ther 290:672-677
114. Ji L, Masuda S, Saito H, Inui K (2002) Down-regulation of rat organic cation transporter rOCT2 by 5/6 nephrectomy. Kidney Int 62:514-524
115. Jigorel E, Le Vee M, Boursier-Neyret C et al (2006) Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes. Drug Metab Dispos 34:1756-1763
116. Jin MJ, Han HK (2006) Interaction of zalcitabine with human organic anion transporter 1. Pharmazie 61:491-492
117. Jung KY, Takeda M, Kim DK et al (2001) Characterization of ochratoxin A transport by human organic anion transporters. Life Sci 69:2123-2135
118. Jung KY, Takeda M, Shimoda M et al. (2002) Involvement of rat organic anion transporter 3 (rOAT3) in cephaloridine-induced nephrotoxicity: in comparison with rOAT1. Life Sci 70:1861-1874
119. Kaler G, Truong DM, Khandelwal A et al (2007) Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. J Biol Chem 282:23841-23853
120. Kaler G, Truong DM, Sweeney DE et al (2007) Olfactory mucosa-expressed organic anion transporter, Oat6, manifests high affinity interactions with odorant organic anions. Biochem Biophys Res Commun 351:872-876
121. Kato Y, Kuge K, Kusuhara H et al (2002) Gender difference in the urinary excretion of organic anions in rats. J Pharmacol Exp Ther 302:483-489
122. Kato Y, Yoshida K, Watanabe C et al (2004) Screening of the interaction between xenobiotic transporters and PDZ proteins. Pharm Res 21:1886-1894
123. Keller T, Schwarz D, Bernhard F et al (2008) Cell free expression and functional reconstitution of eukaryotic drug transporters. Biochemistry 47:4552-4564
124. Khamdang S, Takeda M, Noshiro R et al (2002) Interactions of human organic anion transporters and human organic cation transporters with nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther 303:534-539 (Pubitemid 35231223)
125. Khamdang S, Takeda M, Babu E et al (2003) Interaction of human and rat organic anion transporter 2 with various cephalosporin antibiotics. Eur J Pharmacol 465:1-7
126. Khamdang S, Takeda M, Shimoda M (2004) Interaction of human-and rat-organic anion transporters with pravastatin and cimetidine. J Pharmacol Sci 94:197-202
127. Kikuchi R, Kusuhara H, Sugiyama D, Sugiyama Y (2003) Contribution of organic anion transporter 3 (Slc22a8) to the elimination of p-aminohippuric acid and benzylpenicillin across the blood-brain barrier. J Pharmacol Exp Ther 306:51-58
128. Kikuchi R, Kusuhara H, Hattori N et al (2006) Regulation of the expression of human organic anion transporter 3 by hepatocyte nuclear factor 1a/b and DNA methylation. Mol Pharm 70:887-896
129. Kikuchi R, Kusuhara H, Hattori N et al (2007) Regulation of the tissue-specific expression of the human and mouse urate transporter 1 gene by hepatocyte nuclear factor 1a/b and DNA methylation. Mol Pharm 72:1619-1925
130. Kim G-H, Na KY, Kim S-Y et al (2003) Up-regulation of organic anion transporter 1 protein is induced by chronic furosemide or hydrochlorothiazide infusion in rat kidney. Nephrol Dial Transplant 18:1505-1511
131. Kimura H, Takeda M, Narikawa S et al (2002) Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins. J Pharmacol Exp Ther 301:293-298 (Pubitemid 34250307)
132. Kimura N, Masuda S, Tanihara Y et al (2005) Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1. Drug Metab Pharmacokinet 20:379-386
133. Kimura T, Perry J, Anzai N et al (2007) Development and characterization of immobilized human organic anion transporter based liquid chromatography stationary phase: hOAT1 and hOAT2. J Chromatogr B 15:267-271
134. Kobayashi Y, Hirokawa N, Ohshiro N et al (2002) Differential gene expression of organic anion transporters in male and female rats. Biochem Biophys Res Commun 290:482-487
135. Kobayashi Y, Ohshiro N, Shibusawa T et al (2002) Isolation, characterization and differential gene expression of multispecific organic anion transporter 2 in mice. Mol Pharmacol 62:7-14
136. Kobayashi Y, Ohshiro N, Tsuchiya A et al (2004) Renal transport of organic compounds mediated by mouse organic anion transporter 3 (mOAT3): further substrate specificity of mOAT3. Drug Metab Dispos 32:479-483
137. Kobayashi Y, Ohshiro N, Sakai R et al (2005) Transport mechanism and substrate specificity of human organic anion transporter 2 (hOAT2[SLC22A7]). J Pharm Pharmacol 57:573-578
138. Koepsell H, Endou H (2004) The SLC22 drug transporter family. Pflügers Arch Eur J Physiol 447:666-676
139. Kojima R, Sekine T, Kawachi M et al (2002) Immunolocalization of multispecific organic anion transporters, OAT1, OAT2, and OAT3, in rat kidney. J Am Soc Nephrol 13:848-857
140. Komoda F, Sekine T, Inatomi J et al (2004) The W258X mutation in SLC22A12 is the predominant cause of Japanese renal hypouricemia. Pediatr Nephrol 19:728-733
141. Kusuhara H, Sekine T, Utsunomiya-Tate N et al (1999) Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. J Biol Chem 274:13675-13680
142. Kuze K, Graves P, Leahy A et al (1999) Heterologous expression and functional characterization of a mouse renal organic anion transporter in mammalian cells. J Biol Chem 274:1519-1524
143. Kwak J-O, Kim H-W, Oh K-J et al (2005) Characterization of mouse organic anion transporter 5 as a renal steroid sulfate transporter. J Steroid Biochem Mol Biol 97:369-375
144. Kwak J-O, Kim H-W, Oh K-J et al (2005) Co-localization and interaction of organic anion transporter 1 with caveolin-2 in rat kidney. Exp Mol Med 37:204-212
145. Kwon O, Hong S-M, Blouch K (2007) Alteration in renal organic anion transporter 1 after ischemia/reperfusion in cadaveric renal allografts. J Histochem Cytochem 55:575-584
146. Lacy SA, Hitchcock M J M, Lee WA et al (1998) Effect of oral probenecid coadministration on the chronic toxicity and pharmacokinetics of intravenous cidofovir in cynomolgus monkeys. Toxicol Sci 44:97-106
147. Lalezari JP, Drew WL, Glutzer E et al (1995) (S)-1-[3-hydroxy-2- (phosphonylmethoxy) propyl] cytosine (Cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue. J Infect Dis 171:788-796
148. Leazer TM, Klaassen CD (2003) The presence of xenobiotic transporters in the placenta. Drug Metab Dispos 31:153-167
149. Lee W, Kim RB (2004) Transporters and renal drug elimination. Annu Rev Pharmacol Toxicol 44:137-166
150. Li T, Walsh JR, Ghishan FK, Bai L (2004) Molecular cloning and characterization of a human urate transporter (hURAT1) gene promoter. Biochim Biophys Acta 1681:53-58 (Pubitemid 39550371)
151. Li M, Anderson GD, Wang J (2006) Drug-drug interactions involving membrane transporters in the human kidney. Expert Opin Drug Metab Toxicol 2:505-532
152. Li Y, Sato M, Yanagisawa Y et al (2008) Effects of angiotensin II receptor blockers on renal handling of uric acid in rats. Drug Metab Pharmacokinet 23:263-270
153. Ljubojevic M, Herak-Kramberger CM, Hagos Y et al (2004) Rat renal cortical OAT1 and OAT3 exhibit gender differences determined by both androgen stimulation and estrogen inhibition. Am J Physiol Renal Physiol 287: F124-F138
154. Ljubojevic M, Balen D, Breljak D et al (2007) Renal expression of organic anion transporter Oat2 in rats and mice is regulated by sex hormones. Am J Physiol Renal Physiol 292: F361-F372
155. Lopez-Nieto CE, You GF, Bush KT et al (1997) Molecular cloning and characterization of NKT, a gene product related to the organic cation transporter family that is almost exclusively expressed in the kidney. J Biol Chem 272:6471-6478
156. Lu R, Chan BS, Schuster VL (1999) Cloning of the human PAH transporter: narrow substrate specificity and regulation by protein kinase C. Am J Physiol Renal Physiol 276: F295-F303
157. Maher JM, Slitt AL, Callaghan TN et al (2006) Alterations in transporter expression in liver, kidney, and duodenum after targeted disruption of the transcription factor HNF1alpha. Biochem Pharmacol 72:512-522
158. Manautou JE, Nowicki MT, Aleksunes LM et al (2008) Renal and hepatic transporter expression in type 2 diabetic rats. Drug Metab Lett 2:11-17
159. Matsumoto S, Yoshida K, Ishiguro N et al (2007) Involvement of rat and human organic anion transporter 3 in the renal tubular secretion of topotecan [(S)-9-dimethylaminomethyl-10-hydroxy-camptothecin hydrochloride]. J Pharmacol Exp Ther 322:1246-1252
160. Matsuzaki T, Watanabe H, Yoshitome K et al (2007) Downregulation of organic anion transporters in rat kidney under ischemia/reperfusion-induced acute renal failure. Kidney Int 71:539-547
161. Minematsu T, Hashimoto T, Aoki T et al (2008) Role of the organic anion transporters in the pharmacokinetics of zonampanel, and α-amino-3-hydroxy- 5-methylisoxazole-4-propionate receptor antagonist, in rats. Drug Metab Dispos 36:1496-1504
162. Miyazaki H, Anzai N, Ekaratanawong S et al (2005) Modulation of renal apical organic anion transporter 4 function by two PDZ domain-containing proteins. J Am Soc Nephrol 16:3498-3506
163. Mizuno N, Niwa T, Yotsumoto Y, Sugiyama Y (2003) Impact of drug transporter studies on drug discovery and development. Pharmacol Rev 55:425-461
164. Monte JC, Nagle MA, Eraly SA, Nigam SK (2004) Identification of a novel murine organic anion transporter family member, OAT6, expressed in olfactory mucosa. Biochem Biophys Res Commun 323:429-436
165. Mori K, Ogawa Y, Ebihara K et al (1997) Kidney-specific expression of a novel mouse organic cation transporter-like protein. FEBS Lett 417:371-374
166. Mori S, Takanaga H, Ohtsuki S et al (2003) Rat organic anion transporter 3 (rOAT3) is responsible for brain-to-blood efflux of homovanillic acid at the abluminal membrane of brain capillary endothelial cells. J Cereb Blood Flow Metab 23:432-440
167. Mori S, Ohtsuki S, Takanaga H (2004) Organic anion transporter 3 is involved in the brain-toblood efflux transport of thiopurine nucleobase analogs. J Neurochem 90:931-941
168. Morita N, Kusuhara H, Sekine T et al (2001) Functional characterization of rat organic anion transporter 2 in LLC-PK1 cells. J Pharmacol Exp Ther 298:1179-1184 (Pubitemid 32761937)
169. Motohashi H, Sakurai Y, Saito H et al (2002) Gene expression levels and immunolocalization of organic ion transporters in human kidney. J Am Soc Nephrol 13:866-874
170. Motohashi H, Uwai Y, Hiramoto K et al (2004) Different transport properties between famotidine and cimetidine by human renal organic ion transporters (SLC22A). Eur J Pharmacol 503:25-30
171. Motojima M, Hosokawa A, Yamato H et al (2002) Uraemic toxins induce proximal tubular injury via organic anion transporter 1-mediated uptake. Br J Pharmacol 135:555-563
172. Mulato AS, Ho ES, Cihlar T (2000) Nonsteroidal anti-inflammatory drugs efficiently reduce the transport and cytotoxicity of adefovir mediated by the human renal organic anion transporter 1. J Pharmacol Exp Ther 295:10-15
173. Nagata Y, Kusuhara H, Endou H, Sugiyama Y (2002) Expression and functional characterization of rat organic anion transporter 3 (rOAT3) in the choroid plexus. Mol Pharmacol 61:982-988
174. Nakagomi-Hagihara R, Nakai D, Tokiu T (2007) Inhibition of human organic anion transporter 3 mediated pravastatin transport by gemfibrozil and the metabolites in humans. Xenobiotica 37:416-426
175. Nakajima N, Sekine T, Cha SH et al (2000) Developmental changes in multispecific organic anion transporter 1 expression in rat kidney. Kidney Int 57:1608-1616
176. Nakakariya M, Shima Y, Mitsuoka K et al (2009) Organic anion transporter OAT1 is involved in renal handling of citrullin. Am J Physiol Renal Physiol 297: F71-F79
177. Naud J, Michaud J, Boisvert C et al (2007) Down-regulation of intestinal drug transporters in chronic renal failure in rats. J Pharmacol Exp Ther 320:978-985
178. Nilwarangkoon S, Anzai N, Shiraya K (2007) Role of mouse organic anion transporter 3 (mOAT3) as a basolateral prostaglandin E2 transport pathway. J Pharmacol Sci 103:48-55
179. Nishimura M, Naito S (2005) Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter families. Drug Metab Pharmacokinet 20:452-477
180. Nishiwaki T, Daigo Y, Tamari M et al (1998) Molecular cloning, mapping, and characterization of two novel human genes, ORCTL3 and ORTCL4, bearing homology to organic-cation transporters. Cytogenet Cell Genet 83:251-255
181. Nishizato Y, Ieiri I, Suzuki H et al (2003) Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics. Clin Pharmacol Ther 73:554-565 (Pubitemid 37249126)
182. Nozaki Y, Kusuhara H, Endou H, Sugiyama Y (2004) Quantitative evaluation of the drug-drug interactions between methotrexate and nonsteroidal anti-inflammatory drugs in the renal uptake process based on the contribution of organic anion transporter and reduced folate transporter. J Pharmacol Exp Ther 309:226-234
183. Nozaki Y, Kusuhara H, Kondo T et al (2007) Characterization of the uptake of organic anion transporter (OAT) 1 and OAT3 substrates by human kidney slices. J Pharmacol Exp Ther 321:362-369
184. Nozaki Y, Kusuhara H, Kondo T et al (2007) Species difference in the inhibitory effect of nonsteroidal anti-inflammatory drugs on the uptake of methotrexate by human kidney slices. J Pharmacol Exp Ther 322:1162-1170
185. Obermayr RP, Temml C, Gutjahr G et al (2008) Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol 19:2407-2413
186. Ogasawara K, Terada T, Asaka J-I et al (2006) Human organic anion transporter 3 gene is regulated constitutively and inducibly via a cAMP-responsive element. J Pharmacol Exp Ther 319:317-322
187. Ogasawara K, Terada T, Asaka J-I et al (2007) Hepatocyte nuclear factor-4a regulates the human organic anion transporter 1 gene in the kidney. Am J Physiol Renal Physiol 292: F1819-F1826
188. Ogasawara K, Terada T, Motohashi H et al (2008) Analysis of regulatory polymorphisms in organic ion transporter genes (SLC22A) in the kidney. J Hum Genet 53:607-614
189. Ohtsuki S, Asaba H, Takanaga H et al (2002) Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain. J Neurochem 83:57-66
190. Ohtsuki S, Kikkawa T, Mori S et al (2004) Mouse reduced in osteosclerosis transporter functions as an organic anion transporter 3 and is localized at abluminal membrane of blood-brain barrier. J Pharmacol Exp Ther 309:1273-1281
191. Overbosch D, van Gulpen C, Herman J, Mattie H (1988) The effect of probenecid on the renal tubular excretion of benzylpenicillin. Br J Clin Pharmacol 25:51-58
192. Pavlova A, Sakurai H, Leclercq B et al (2000) Developmentally regulated expression of organic ion transporters NKT (OAT1), OCT1, NLT (OAT2), and Roct. Am J Physiol Renal Physiol 278: F635-F643
193. Perry JL, Dembla-Rajpal N, Hall LA, Pritchard JB (2006) A three-dimensional model of human organic anion transporter 1. Aromatic amino acids required for substrate transport. J Biol Chem 281:38071-38079
194. Pfohl-Leszkowics A, Manderville RA (2007) Ochratoxin A: an overview on toxicity and carcinogenicity in animals and humans. Mol Nutr Food Res 51:61-99
195. Pombrio JM, Giangreco A, Li L et al (2001) Mercapturic acids (N-acetylcysteine-S-conjugates) as endogenous substrates for the renal organic anion transporter 1. Mol Pharmacol 60:1091-1099
196. Popowski K, Eloranta JJ, Saborowski M et al (2005) The human organic anion transporter 2 gene is transactivated by hepatocyte nuclear factor-4a and suppressed by bile acids. Mol Pharm 67:1629-1638
197. Price KL, Sautin YY, Long DA et al (2006) Human vascular smooth muscle cells express a urate transporter. J Am Soc Nephrol 17:1791-1795
198. Pritchard JB, Sweet DH, Miller DS, Walden R (1999) Mechanism of organic anion transport across the apical membrane of choroid plexus. J Biol Chem 274:33382-33387
199. Prueksaritanont T, Hochman JH, Meng Y et al (2004) Renal elimination of a novel and potent avb3 integrin antagonist in animals. Xenobiotica 34:1059-1974
200. Race JE, Grassl SM, Williams WJ, Holtzmann EJ (1999) Molecular cloning and characterization of two novel human renal organic anion transporters (hOAT1 and hOAT3). Biochem Biophys Res Commun 255:508-514
201. Reid G, Wolff NA, Dautzenberg FM, Burckhardt G (1998) Cloning of a human renal p-aminohippurate transporter, hROAT. Kidney Blood Press Res 21:233-237
202. Rizwan AN, Burckhardt G (2007) Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles. Pharm Res 24:450-470
203. Rizwan AN, Krick W, Burckhardt G (2007) The chloride dependence of human organic anion transporter 1 (hOAT1) is blunted by mutation of a single amino acid. J Biol Chem 282:13402-13409
204. Saito H (2010) Pathophysiological regulation of renal SLC22A organic ion transporters in acute kidney injury: pharmacological and toxicological implications. Pharmacol Ther 125(1):79-91, Epub 2009 Oct. 24
205. Saji T, Kikuchi R, Kusuhara H et al (2008) Transcriptional regulation of human and mouse organic anion transporter 1 by hepatocyte nuclear factor 1 a/b. J Pharmacol Exp Ther 324:784-790
206. Sakurai Y, Motohashi H, Ueo H et al (2004) Expression levels of renal organic anion transporters (OATs) and their correlation with anionic drug excretion in patients with renal diseases. Pharm Res 21:61-67
207. Sato M, Iwanaga T, Mamada H et al (2008) Involvement of uric acid transporters in alteration of serum uric acid level by angiotensin II receptor blockers. Pharm Res 25:639-646
208. Sauvant C, Holzinger H, Gekle M (2002) Short-term regulation of basolateral organic anion uptake in proximal tubular OK cells: EGF acts via MAPK, PLA2, and COX1. J Am Soc Nephrol 13:1981-1991
209. 2 acts via receptor-mediated activation of protein kinase A. J Am Soc Nephrol 14:3017-3026
210. Sauvant C, Hesse D, Holzinger H et al (2004) Action of EGF and PGE2 on basolateral organic anion uptake in rabbit proximal renal tubules and hOAT1 expressed in human kidney epithelial cells. Am J Physiol Renal Physiol 286: F774-F783
211. 2 inhibits its own renal transport by downregulation of organic anion transporters rOAT1 and rOAT3. J Am Soc Nephrol 17:46-53
212. Schnabolk GW, Youngblood GL, Sweet DH (2006) Transport of estrone sulfate by the novel organic anion transporter Oat6 (Slc22a20). Am J Physiol Renal Physiol 291: F314-F321
213. Schneider R, Sauvant C, Betz B et al (2007) Downregulation of organic anion transporters OAT1 and OAT3 correlates with impaired secretion of para-aminohippurate after ischemic acute renal failure in rats. Am J Physiol Renal Physiol 292: F1599-F1605
214. Schneider R, Meusel M, Renker S et al (2009) Low-dose indomethacin after ischemic acute kidney injury prevents down regulation of Oat1/3 and improves renal outcome. Am J Physiol Renal Physiol 297: F1614-F1621
215. Schömig E, Spitzenberger F, Engelhardt M et al (1998) Molecular cloning and characterization of two novel transport proteins from rat kidney. FEBS Lett 425:79-86
216. Sekine T, Watanabe N, Hosoyamada M et al (1997) Expression cloning and characterization of a novel multispecific organic anion transporter. J Biol Chem 272:18526-18529
217. Sekine T, Cha SH, Tsuda N et al (1998) Identification of multispecific organic anion transporter 2 expressed predominantly in liver. FEBS Lett 429:179-182
218. Sekine T, Cha SH, Endou H (2000) The multispecific organic anion transporter (OAT) family. Pflügers Arch Eur J Physiol 440:337-350
219. Shah MM, Tee JB, Meyer T et al (2009) The instructive role of metanephric mesenchyme in ureteric bud patterning, sculpting, and maturation and its potential ability to buffer ureteric bud branching defects. Am J Physiol Renal Physiol 297: F1330-F1341
220. Shibayama Y, Ushinohama K, Ikeda R et al (2006) Effect of methotrexate treatment on expression levels of multidrug resistance protein 2, breast cancer resistance protein and organic anion transporters Oat1, Oat2 and Oat3 in rats. Cancer Sci 96:1260-1266
221. 99mTc-MAG3 via rat renal organic anion transporter 1. J Nucl Med 45:80-84
222. Shin HJ, Anzai N, Enomoto A et al (2007) Novel liver-specific organic anion transporter OAT7 that operates the exchange of sulfate conjugates for short chain fatty acid butyrate. Hepatology 45:1046-1055
223. Shitara Y, Sato H, Sugiyama Y (2005) Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs. Annu Rev Pharmacol Toxicol 45:689-723
224. Simonson GD, Vincent AC, Roberg KJ et al (1994) Molecular cloning and characterization of a novel liver-specific transport protein. J Cell Sci 7:1065-1072
225. Soodvilai S, Chatsudthipong V, Evans KK et al (2004) Acute regulation of OAT3-mediated estrone sulfate transport in isolated rabbit renal proximal tubules. Am J Physiol Renal Physiol 287: F1021-1029
226. Soodvilai S, Wright SH, Dantzler WH, Chatsudthipong V (2005) Involvement of tyrosine kinase and PI3K in the regulation of OAT3-mediated estrone sulfate transport in isolated rabbit renal proximal tubules. Am J Physiol Renal Physiol 289: F1057-F1064
227. Srimaroeng C, Chatsudthipong V, Aslamkhan AG, Pritchard JB (2005) Transport of the natural sweetener stevioside and its aglycone steviol by human organic anion transporter (hOAT1; SLC22A6) and hOAT3 (SLC22A8). J Pharmacol Exp Ther 313:621-628
228. Srimaroeng C, Jutabha P, Pritchard JB et al (2005) Interactions of stevioside and steviol with renal organic anion transporters in S2 cells and mouse renal cortical slices. Pharm Res 22:858-866
229. Srimaroeng C, Perry JL, Pritchard JB (2008) Physiology, structure, and regulation of the cloned organic anion transporters. Xenobiotica 38:889-935
230. Sugawara M, Mochizuki T, Takekuma Y, Miyazaki K (2005) Structure-activity relationship in the interactions of human organic anion transporter 1 with caffeine, theophylline, theobromine and their metabolites. Biochim Biophys Acta 1714:85-92
231. Sugiyama D, Kusuhara H, Shitara Y et al (2001) Characterization of the efflux transport of 17ß-estradiol-D-17ß-glucuronide from the brain across the blood-brain barrier. J Pharmacol Exp Ther 298:316-322 (Pubitemid 32574542)
232. Sun W, Wu RR, van Poelje PD, Erion MD (2001) Isolation of a family of organic anion transporters from human liver and kidney. Biochem Biophys Res Commun 283:417-423
233. Sweet DH (2005) Organic anion transporter (Slc22a) family members as mediators of toxicity. Toxicol Appl Pharmacol 204:198-215
234. Sweet DH, Wolff NA, Pritchard JB (1997) Expression cloning and characterization of ROAT1. J Biol Chem 272:30088-30095
235. Sweet DH, Miller DS, Pritchard JB et al (2002) Impaired organic anion transport in kidney and choroid plexus of organic anion transporter 3 (Oat3 (Slc22a8)) knockout mice. J Biol Chem 277:26934-26943
236. + gradient. Am J Physiol Renal Physiol 284: F763-F768
237. Sweet DH, Eraly SA, Vaughn DA et al (2006) Organic anion and cation transporter expression and function during embryonic kidney development and in organ culture models. Kidney Int 69:837-845
238. Tahara H, Kusuhara H, Endou H et al (2005) A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters. J Pharmacol Exp Ther 315:337-345
239. Tahara H, Shono M, Kusuhara H et al (2005) Molecular cloning and functional analysis of OAT1 and OAT3 from Cynomolgus monkey kidney. Pharm Res 22:647-660
240. Tahara H, Kusuhara H, Chida M et al (2006) Is the monkey an appropriate animal model to examine drug-drug interactions involving renal clearance? Effect of probenecid on the renal elimination of H2 receptor antagonists. J Pharmacol Exp Ther 316:1187-1194
241. Tahara H, Kusuhara H, Maeda K et al (2006) Inhibition of OAT3-mediated renal uptake as a mechanism for drug-drug interaction between fexofenadine and probenecid. Drug Metab Dispos 34:743-747
242. Takeda M, Tojo A, Sekine T et al (1999) Role of organic anion transporter 1 (OAT1) in cephaloridine (CER9)-induced nephrotoxicity. Kidney Int 56:2128-2136
243. Takeda M, Hosoyamada M, Cha SH et al (2000) Hydrogen peroxide downregulates human organic anion transporters in the basolateral membrane of the proximal tubule. Life Sci 68:679-687
244. Takeda M, Sekine T, Endou H (2000) Regulation by protein kinase C of organic anion transport driven by rat organic anion transporter 3 (rOAT3). Life Sci 67:1087-1093
245. Takeda M, Narikawa S, Hosoyamada M et al (2001) Characterization of organic anion transport inhibitors using cells stably expressing human organic anion transporters. Eur J Pharmacol 419:113-120
246. Takeda M, Babu E, Narikawa S, Endou H (2002) Interaction of human organic anion transporters with various cephalosporin antibiotics. Eur J Pharmacol 438:137-142 (Pubitemid 34241501)
247. Corrigendum in Eur J Pharmacol 450:111
248. Takeda M, Khamdang S, Narikawa S et al (2002) Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. J Pharmacol Exp Ther 300:918-924 (Pubitemid 34164996)
249. Takeda M, Khamdang S, Narikawa S et al (2002) Characterization of methotrexate transport and its drug interactions with human organic anion transporters. J Pharmacol Exp Ther 302:666-671
250. Takeda M, Noshiro R, Onozato ML et al (2004) Evidence for a role of human organic anion transporters in the muscular side effects of HMG-CoA reductase inhibitors. Eur J Pharmacol 483:133-138
251. Tanaka K, Xu W, Zhou F, You G (2004) Role of glycosylation in the organic anion transporter 1. J Biol Chem 279:14961-14966 (Pubitemid 38618888)
252. Terlouw SA, Masereeuw R, Russel F G M (2003) Modulatory effects of hormones, drugs, and toxic events on renal organic anion transport. Biochem Pharmacol 265:1393-1404
253. Thyss A, Milano G, Kubar J et al (1986) Clinical and pharmacokinetic evidence of a lifethreatening interaction between methotrexate and ketoprofen. Lancet 1:256-258
254. Tojo A, Sekine T, Nakjima N et al (1999) Immunohistochemical localization of multispecific renal organic anion transporter 1 in rat kidney. J Am Soc Nephrol 10:464-471 (Pubitemid 29117627)
255. Torres AM (2008) Renal elimination of organic anions in cholestasis. World J Gastroenterol 14:6616-6621
256. Truong DM, Kaler G, Khandelwal A et al (2008) Multi-level analysis of organic anion transporters 1, 3, and 6 reveals major differences in structural determinants of antiviral discrimination. J Biol Chem 283:8654-8663
257. Tsuda M, Sekine T, Takeda M et al (1999) Transport of ochratoxin A by renal multispecific organic anion transporter 1. J Pharmacol Exp Ther 289:1301-1305 (Pubitemid 29246658)
258. Tsuji A, Terasaki T, Tamai I, Takeda K (1990) In vivo evidence for carrier-mediated uptake of ß-lactam antibiotics through organic anion transport systems in rat kidney and liver. J Pharmacol Exp Ther 253:315-320
259. Ueo H, Motohashi H, Katsura T, Inui K-I (2005) Human organic anion transporter hOAT3 is a potent transporter of cephalosporin antibiotics, in comparison with hOAT1. Biochem Pharmacol 70:1104-1113
260. Ueo H, Motohashi H, Inui K (2007) Cl-dependent up-regulation of human organic anion transporters: different effects on transport kinetics between hOAT1 and hOAT3. Am J Physiol Renal Physiol 293: F391-F397 (Pubitemid 47345040)
261. Ugele B, St-Pierre MV, Pihusch M et al (2003) Characterization and identification of steroid sulfate transporters in human placenta. Am J Physiol Endocrinol Metab 284: E390-E398
262. Ugele B, Bahn A, Rex-Haffner M (2008) Functional differences in steroid sulfate uptake of organic anion transporter 4 (OAT4) and organic anion transporting polypeptide 2B1 (OATP2B1) in human placenta. J Steroid Biochem Mol Biol 111:1-6
263. Urakami Y, Nakamura N, Takahashi K et al (1999) Gender differences in expression of organic cation transporter OCT2 in rat kidney. FEBS Lett 461:339-342
264. Urban TJ, Sebro R, Hurowitz EH et al (2006) Functional genomics of membrane transporters in human populations. Genome Res 16:2223-2230
265. Uwai Y, Okuda M, Takami K et al (1998) Functional characterization of the rat multispecific organic anion transporter OAT1 mediating basolateral uptake of anionic drugs in the kidney. FEBS Lett 438:321-324
266. Uwai Y, Saito H, Hashimoto Y, Inui K (2000) Inhibitory effect of anti-diabetic agents on rat organic anion transporter rOAT1. Eur J Pharmacol 398:193-197
267. Uwai Y, Saito H, Hashimoto Y, Inui K (2000) Interaction and transport of thiazide diuretics, loop diuretics, and acetazolamide via rat renal organic anion transporter rOAT1. J Pharmacol Exp Ther 295:261-265
268. Uwai Y, Saito H, Inui K (2000) Interaction between methotrexate and nonsteroidal antiinflammatory drugs in organic anion transporter. Eur J Pharmacol 409:31-36
269. Uwai Y, Taniguchi R, Motohashi H et al (2004) Methotrexate-loxoprofen interaction: Involvement of human organic anion transporters hOAT1 and hOAT3. Drug Metab Dispos 19:369-374
270. Uwai Y, Ida H, Tsuji Y et al (2007) Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2). Pharm Res 24:811-815
271. Uwai Y, Motohashi H, Tsuji Y et al (2007) Interaction and transport characteristics of mycophenolic acid and its glucuronide via human organic anion transporters hOAT1 and hOAT3. Biochem Pharmacol 74:161-168
272. Vallon V, Eraly S, Wikoff WR et al (2008) Organic anion transporter 3 contributes to the regulation of blood pressure. J Am Soc Nephrol 19:1732-1740
273. Vallon V, Rieg T, Ahn SY et al (2008) Overlapping in vitro and in vivo specificities of the organic anion transporters OAT1 and OAT3 for loop and thiazide diuretics. Am J Physiol Renal Physiol 294: F867-F873
274. van Aubel R A M H, Masereeuw R, Russel F G M (2000) Molecular pharmacology of renal organic anion transporters. Am J Physiol Renal Physiol 279: F216-F232
275. van Montfoort JE, Meijer D K F, Groothuis G M M et al (2003) Drug uptake systems in liver and kidney. Curr Drug Metab 4:185-211
276. Vanholder R, De Smet R, Glorieux G, for the European Uremic Toxin Work Group (EUTox) et al (2003) Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 63:1934-1943
277. VanWert AL, Bailey RM, Sweet DH (2007) Organic anion transporter 3 (Oat3/Slc22a8) knockout mice exhibit altered clearance and distribution of penicillin G. Am J Physiol Renal Physiol 293: F1332-F1341
278. VanWert AL, Sweet DH (2007) Impaired clearance of methotrexate in organic anion transporter 3 (Slc22a8) knockout mice: a gender specific impact on reduced folates. Pharm Res 25:453-462
279. VanWert AL, Srimaroeng C, Sweet DH (2008) Organic anion transporter 3 (Oat3/Slc22a8) interacts with carboxyfluoroquinolones, and deletion increases systemic exposure to ciprofloxacin. Mol Pharm 74:122-131
280. VanWert AL, Gionfriddo MR, Sweet DH (2010) Organic anion transporters: discovery, pharmacology, regulation and roles in pathopysiology. Biopharm Drug Dispos 31:1-71
281. Villar SR, Brandoni A, Anzai N et al (2005) Altered expression of rat renal cortical OAT1 and OAT3 in response to bilateral ureteral obstruction. Kidney Int 68:2704-2713
282. Villar SR, Brandoni A, Torres AM (2008) Time course of organic anion excretion in rats with bilateral ureteral obstruction: role of organic anion transporters (Oat1 and Oat3). Nephron Physiol 110: p45-p56
283. Vree TB, van den Biggelaar-Martea M, Verwey-van Wissen C P W G M (1995) Probenecid inhibits the renal clearance of frusemide and its acyl glucuronide. Br J Clin Pharmacol 39:692-695
284. Wada S, Tsuda M, Sekine T et al (2000) Rat multispecific organic anion transporter 1 (rOAT1) transports zidovudine, acyclovir, and other antiviral nucleoside analogs. J Pharmacol Exp Ther 294:844-849
285. Windass AS, Lowes S, Wang Y, Brown C D A (2007) The contribution of organic anion transporters OAT1 and OAT3 to the renal uptake of rosuvastatin. J Pharmacol Exp Ther 322:1221-1227
286. Wolff NA, Werner A, Burkhardt S, Burckhardt G (1997) Expression cloning and characterization of a renal organic anion transporter from winter flounder. FEBS Lett 417:287-291
287. Wolff NA, Thies K, Kuhnke N et al (2003) Protein kinase C activation downregulates human organic anion transporter 1-mediated transport through carrier internalization. J Am Soc Nephrol 14:1959-1968
288. Wolff NA, Burckhardt BC, Burckhardt G et al (2007) Mycophenolic acid (MPA) and its glucuronide metabolites interact with transport systems responsible for excretion of organic anions in the basolateral membrane of human kidney. Nephrol Dial Transplant 22:2497-2503
289. Wood CE, Coursins R, Zhang D, Keller-Wood M (2005) Ontogeny of expression of organic anion transporters 1 and 3 in ovine fetal and neonatal kidney. Exp Biol Med 230:668-673
290. Wright SH, Dantzler WB (2004) Molecular and cellular physiology of renal organic cation and anion transport. Physiol Rev 84:987-1049
291. Xu G, Bhatnagar V, Wen G et al (2005) Analyses of coding region polymorphisms in apical and basolateral human organic anion transporter (OAT) genes [OAT1 (NKT), OAT2, OAT3, OAT4, URAT1 (RST)]. Kidney Int 68:1491-1499
292. Xu G, Chen X, Wu D et al (2006) Development of high-specificity antibodies against renal urate transporters using genetic immunization. J Biochem Mol Biol 39:696-702
293. Xu G, Tanaka K, Sun A-Q, You G (2006) Functional role of the C-terminus of human organic anion transporter hOAT1. J Biol Chem 281:31178-31183
294. Yamada A, Maeda K, Kamiyama E et al (2007) Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor. Drug Metab Dispos 35:2166-2176
295. Yamashita F, Ohtani H, Koyabu N et al (2006) Inhibitory effects of angiotensin II receptor antagonists and leukotriene receptor antagonists on the transport of human organic anion transporter 4. J Pharm Pharmacol 58:1499-1505
296. Yokoyama H, Anzai N, Ljubojevic M et al (2008) Functional and immunochemical characterization of a novel organic anion transporter Oat8 (Slc22a9) in rat renal collecting duct. Cell Physiol Biochem 21:269-278
297. 1 cells. J Biol Chem 275:10278-10284
298. Youngblood GL, Sweet DH (2004) Identification and functional assessment of the novel murine organic anion transporter Oat5 (Slc22a19) expressed in kidney. Am J Physiol Renal Physiol 287: F236-F244
299. Yuan H, Feng B, Yu Y et al (2009) Renal organic anion transporter-mediated drug-drug interaction between gemcabene and quinapril. J Pharmacol Exp Ther 330:191-197
300. Zalups RK, Ahmad S (2005) Transport of N-acetyl-S-cysteine conjugates of methylmercury in Madin-Darby canine kidney cells stably transfected with human isoform of organic anion transporter 1. J Pharmacol Exp Ther 314:1158-1168
301. Zhang X, Groves CE, Bahn A et al (2004) Relative contribution of OAT and OCT transporters to organic electrolyte transport in rabbit proximal tubule. Am J Physiol Renal Physiol 287: F999-F1010
302. Zhang Q, Hong M, Duan P et al (2008) Organic anion transporter OAT1 undergoes constitutive and protein kinase C-regulated trafficking through a dynamin-and clathrin-dependent pathway. J Biol Chem 283:32570-32579
303. Zhou F, Pan Z, Ma J, You G (2004) Mutational analysis of histidine residues in human organic anion transporter 4 (hOAT4). Biochem J 384:87-92 (Pubitemid 39564164)
304. Zhou F, Tanaka K, Pan Z et al (2004) The role of glycine residues in the function of human organic anion transporter 4. Mol Pharm 65:1141-1147 (Pubitemid 38543485)
305. Zhou F, Xu W, Hong M et al (2005) The role of N-linked glycosylation in protein folding, membrane targeting, and substrate binding of human organic anion transporter OAT4. Mol Pharm 67:868-876
306. Zhou F, Illsley NP, You G (2006) Functional characterization of a human organic anion transporter hOAT4 in placental BeWo cells. Eur J Pharm Sci 27:518-523
307. Zhou F, Hong M, You G (2007) Regulation of the human organic anion transporter 4 by progesterone and protein kinase C in human placental BeWo cells. Am J Physiol Endocrinol Metab 293: E57-E61
308. Zhou F, Xu W, Tanaka K, You G (2007) Comparison of the interaction of human organic anion transporter hOAT4 with PDZ proteins between kidney cells and placental cells. Pharm Res 25:475-480
309. Zlender V, Breljak D, Ljubojevic M et al (2009) Low doses of ochratoxin A upregulate the protein expression of organic anion transporters Oat1, Oat2, Oat3 and Oat5 in rat kidney cortex. Toxicol Appl Pharmacol 239:284-296